© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
206115 |
As an accredited 4,6-Dibromopyrimidine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 4,6-Dibromopyrimidine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
4,6-Dibromopyrimidine doesn't always grab headlines in chemistry circles, but those who spend their days in labs or production spaces have noticed the quiet workhorse role it pulls off. Pyrimidine itself stands out as a core structure in DNA and many pharmaceuticals. Once chemists start attaching halogens like bromine at specific points—positions 4 and 6 in this case—the molecule becomes much more versatile. My own time mixing and heating batches of fine chemicals has left me stubbornly loyal to reagents that respond predictably, and this compound falls squarely in that camp.
I've watched colleagues at pharmaceutical startups comb the catalogues for reliable building blocks, searching for molecules that shave weeks off multi-step syntheses. 4,6-Dibromopyrimidine enters the scene here, often helping to bridge the gap between basic heterocycle and high-value, biologically active compound. With both bromines strategically placed, it serves as a reactive node—just the sort chemists look for in cross-coupling reactions. Amid the piles of bottles and spreadsheets, its utility really stands out.
Peering at the bottle, you spot the model or reference code, usually attached by major chemical suppliers. Whether it gets labeled as high purity, analytical grade, or some internal batch number, experienced chemists don't just stop at the sticker. They pay attention to the look and feel of the solid—4,6-Dibromopyrimidine typically appears as a pale white to off-white crystalline powder. Even the smell, faint and characteristic, signals its identity, though of course no one goes around inhaling fine chemicals on purpose. With melting points consistently reported around 153-155°C and a molecular formula of C4H2Br2N2, it's a substance whose expected properties line up in real-world use.
Specifications always matter for those looking to minimize headaches in the lab. Most reputable sources ship this compound with purities exceeding 98%, sometimes pushing towards 99%—enough for most high-stakes research and process development efforts. Trace impurities like related pyrimidine derivatives or unreacted starting materials tend to fall below the quantification limits when detailed HPLC analyses are available. If questions pop up about solubility, users soon find out it doesn't mingle much with water but does dissolve well in organic solvents like dichloromethane, tetrahydrofuran, or acetonitrile, which isn't news for anyone who has handled halogenated aromatics before.
I've helped design routes for specialty pharma, and I've seen chemists navigate long routes stacked with tedious purifications. 4,6-Dibromopyrimidine, though, often makes things simpler by acting as a launchpad for more elaborate molecular frameworks. It serves best as an electrophilic component in cross-coupling protocols—Suzuki, Stille, and Buchwald-Hartwig reactions come to mind for almost anyone in synthetic organic chemistry. Here, the twin bromines act like carefully poised triggers, allowing selective or sequential substitution at either carbon position.
This strategy pays dividends in the creation of anti-viral agents, kinase inhibitors, and agrochemical actives. Academic papers and patents alike base entire molecular families on these sorts of dibromo-activated intermediates. For those trained in the old-school art of stepwise synthesis, swapping both positions with complex nucleophiles—aryls, amines, or even alkynes—has become routine. This approach opens up access to libraries of pyrimidine analogs, which frequently end up in preclinical screens or structure-activity relationship campaigns.
Not every use story comes from high-tech biotech or big pharma. Some researchers, myself included, have used 4,6-Dibromopyrimidine to synthesize dyes, optical brighteners, or ligands for advanced materials. It slots in as a customizable scaffold when there's a need for electronic communication across a molecule, or simply to introduce polarity or rigidity at the right time.
Plenty of chemists look at dibrominated pyrimidines and ask how 4,6-Dibromopyrimidine really sets itself apart from siblings like 2,4-, 2,6-, or 2,5-dibromopyrimidine. After using them all in a string of syntheses, I find the 4,6- variant often leads to the fewest headaches. The unique combination of reactive sites avoids snarls with undesired regioisomer formation. Other positions, especially those with bromine at both the 2- and 4- spots, can lead to uneven substitution patterns, which eventually means trickier purification.
The 4,6 compound is also a little more forgiving with some of the classic cross-coupling catalysts, like palladium or nickel. I've personally seen yields go up just because the reaction favors a clean and complete conversion from dibromo intermediate to the final, more decorated pyrimidine. This makes it the go-to for quick library generation, a big selling point in drug discovery campaigns where time to hit matters. Those running automated or parallel syntheses appreciate the predictability, which cuts down on unnecessary reruns and stretches tight budgets just a bit further.
No one likes surprises in the chemistry lab, especially when they're handling halogenated aromatics like 4,6-Dibromopyrimidine. Working safely always takes center stage. This compound generally behaves as expected—stable under ambient conditions, not especially prone to decomposition, but like most organobromides, it's wise to keep it sealed and away from strong bases or reducing agents. As always, gloves, glasses, and solid ventilation ensure peace of mind.
Quality matters not just in big GMP or GLP labs, but also in scrappier academic settings. Analytical certificates, GC and HPLC traces, and batch-specific data have become standard fare, making it easier to compare lots. Those in the business of scale-up know just how much a subtle impurity in a kilogram can scramble timelines and budgets downstream. Years ago, I dealt with a surprise byproduct in an order of this same molecule, and it only took a good QC team to spot the culprit—a tiny peak on the chromatogram, invisible to the naked eye, would later be the reason a whole batch had to be reworked. This experience only hardened my appreciation for keeping the paperwork and checks in line.
Longtime users develop an intuition for the handful of companies that won't short the paperwork or skip batch controls. Many researchers chat on forums or during conference coffee breaks, trading stories about surprise color changes, unexpected melting points, or new impurity peaks. These small signals, often caught during the preparation of reference standards, influence where repeat orders land in the years that follow.
Chemical production doesn't happen in isolation from the world. Making 4,6-Dibromopyrimidine at scale involves careful juggling of raw material sourcing, waste handling, and compliance with shifting regulatory frameworks. Environmental impact hangs over all halogenated organics—two bromines per molecule means downstream waste streams need scrupulous treatment to avoid contributing to persistent organic pollutants.
Having worked with colleagues in green chemistry, it's clear that pressure from environmental authorities nudges producers toward cleaner processes. Some now explore alternative brominating agents or closed-loop recovery systems for solvents. The shift takes time and persistence, but the trend feels inexorable. Chemists keen on sustainability probe their suppliers about solvent recovery, energy inputs, and lifecycle assessments before ordering multi-kilogram lots. Such scrutiny, which once raised eyebrows, is now a fixture in tender documents and purchasing guidelines at companies watching their ecological footprint.
There's a knowledge gap out there too, with some early-career researchers needing more tools to evaluate whether alternatives can do the same job. Training on green reaction design, especially with halogenated intermediates, should run alongside traditional organic coursework. A few universities have started to pair synthesis modules with real-world lifecycle impact exercises; from my time as a visiting lecturer, I can say those lessons stick with students much longer than lists of melting points or TLC solvent ratios.
The reinvention of pyrimidine chemistry in the past decade owes a lot to clever intermediates like 4,6-Dibromopyrimidine. Advances in catalyst science, often tied to the relentless pace of pharmaceutical lead optimization, have given the dibromo core a surprising second life. Cross-coupling reactions that were once unpredictable or fussy now unwrap with a streamlined setup—sometimes run in parallel microwell reactors or high-throughput screens, leaving time for more interesting fine-tuning.
Case studies abound. Research groups working on antitumor compounds rely on the dibromo template when exploring structure-activity relationships. In agricultural chemistry, tweaking the substituents on pyrimidines via the 4 and 6 positions has yielded new classes of fungicides and insecticides—a topic that remains vital as the world chases improved crop yields with lower resistance risk.
There's also a surge in combining classic heterocyclic synthesis with newer platform technologies. Flow chemistry rigs, now common in pilot plants and even teaching labs, allow the controlled introduction of such intermediates, where heat, time, and reagent flow get monitored minute-by-minute. In my own experience, flow methods have trimmed both time and material waste for certain scale-up projects involving dibrominated aromatics. While not without headache—the right reactor lining, pump tolerances, and sensor calibration matter a lot—the systems reward patience and iterative tweaking.
Price and supply used to be straightforward—order, wait a week, and unpack the bottle. These days, things look a little different. Pandemic-era disruptions, international shipping snarls, and new customs rules have made old assumptions obsolete. Sourcing 4,6-Dibromopyrimidine—especially in specialty grades or larger batches—sometimes means checking backorder notices or chasing up with sales reps. Friends running pilot-scale labs in different countries swap tips about which brokers have reliable stock or how to finesse local import rules.
Pricing floats with feedstock costs. Bromine and pyrimidine derivatives track broader commodity trends, so it's not rare to see a price swing over the course of a year. Savvy purchasing managers now lock in contracts or coordinate group buying among collaborating labs, a practice I picked up after losing two weeks on a project during a supply crunch. Those planning big campaigns set up rolling forecasts and cross-check with multiple suppliers—hardly glamorous work, but it keeps projects on track.
Accessibility shouldn't be a privilege in research chemistry. Open channels, clear documentation, and honest communication between supplier and end user help manage expectations. Whether working out of a cutting-edge pharma campus or a university basement, every chemist deserves the chance to put good building blocks to use. Modern supply chain realities test patience, but clear heads and open lines keep the wheels moving. From my own experience, the simplest way to avoid surprises is to maintain a running dialogue with the purchasing team, logistics partners, and the technical support folks who keep the pipeline filled.
4,6-Dibromopyrimidine has proven its worth in both early exploratory programs and more routine industrial manufacturing. The path from bench-scale discovery to robust process scale can take years, with countless decision points about which intermediates to use and how to optimize them. Teams hung up on a bottleneck intermediate or unpredictable reactivity patterns can lose precious momentum; compounds like this, which answer the call for reactivity and predictability, earn their spot on procurement lists year after year.
Chemists often push technology at the margins, asking older tools to do things undreamed of a generation ago. In my group, we learned to blend traditional batchwise methods with robotic liquid handling and predictive software. Intermediates like 4,6-Dibromopyrimidine, thanks to familiar behavior, act as the bridge between new and old methods—still relevant, still powerful, and comfortably sitting at the backbone of new strategies.
Industrial catalysis, too, looks to stable and reactive intermediates. Building out libraries of supported catalysts, ligand precursors, or new chelation motifs often starts with the pyrimidine ring. Catalysis researchers I know in multinational companies swear by dibrominated systems for creating ligands that boost the performance of metal complexes—transforming simple reactions into streamlined, industrially relevant steps.
Passing down the craft of chemistry means showing not just the flashy reactions, but the value of bread-and-butter reagents like 4,6-Dibromopyrimidine. I enjoy walking students through the nitty-gritty of selecting intermediates—not every session sparks wild enthusiasm at first, but hands-on experimentation quickly changes minds. Watching a clean product drop out of a reaction, or seeing crystallinity form as solvent evaporates, turns an abstract line in a protocol into something tangible.
Teaching the virtues of well-chosen reagents involves more than memorizing structures or supplier catalog numbers. Chemists learn the hard way which bottles get a place on the shelf and which stay in the storeroom. Hard-won stories about batch-to-batch consistency, failed purifications, or surprise regulatory hurdles catch students off guard at first, but these lessons cement themselves quickly with each new experiment or troubleshooting session.
Workshops and remote learning can't replace hands-on time, but I've had good success layering theory with practical case studies. Using 4,6-Dibromopyrimidine as an example frequently helps graduate students connect classic cross-coupling routes with the challenges of turning a concept into a robust process. The jump from paper chemistry to production-scale realities—cost, access, solvent hazards, and all—comes alive much faster with real chemical names and tangible observations.
Like much of the chemical toolbox, 4,6-Dibromopyrimidine faces new challenges each year. Sustainability requirements sharpen, global competition increases, and young chemists enter the field with high expectations for process safety, waste minimization, and robust documentation. As an industry, chemistry grows by blending tradition with innovation. Advances in green chemistry suggest a path forward, from new catalytic cycles that avoid toxic solvents to improved downstream cleanup methods. Real change takes buy-in from both suppliers and users, and it's encouraging to see industrial partners invest in cleaner bromination processes and enhanced batch controls.
Open communication across the field also matters—chemistry advances fastest when those on the front lines talk freely about problems and workarounds. Community forums, open-access publications, and in-person conferences foster a culture that values transparency, evidence, and experience above hype or hollow buzzwords.
As journeys in chemistry go, each new reagent or intermediate tells its own story. Over the years, bottles of 4,6-Dibromopyrimidine have found their way onto my shelves, sometimes for routine preparations, sometimes as the linchpin in a patent application. Science rewards reliability, and molecules like this, simple in structure but wide in utility, keep laboratories productive and inventors moving ahead.
